| Daniel Barlow, | |
|
2375 Champions Blvd, Auburn, AL 36830-6471 | |
| (603) 650-7692 | |
| Not Available |
| Full Name | Daniel Barlow |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 2375 Champions Blvd, Auburn, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457738338 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD.41142 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| East Alabama Medical Center And Snf | Opelika, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Primary Medicine Associates, Llc | 7214089432 | 9 |
News Archive
Vertex Pharmaceuticals Incorporated today announced a modification of its Phase 2 clinical trial evaluating 12-week, response-guided regimens of its lead investigational hepatitis C virus (HCV) protease inhibitor, telaprevir, in combination with its lead investigational HCV polymerase inhibitor, VX-222.
Noroviruses are a leading cause of acute gastroenteritis (diarrhoea and vomiting) across all age groups, responsible for almost a fifth (18%) of all cases worldwide. New estimates, published in The Lancet Infectious Diseases, highlight the importance of developing norovirus vaccines, say the authors.
Scientists have devised a simple test for an earlier and more accurate warning of returning bladder cancer than existing methods, according to research published in the British Journal of Cancer today (Friday).
Naturxan, LLC, a joint venture between Archer Daniels Midland Company and Igene Biotechnology, Inc., today announced that it has completed an expansion of its production and distribution capabilities to provide worldwide availability of Aquasta, a naturally sourced astaxanthin made from Phaffia yeast for enriching and pigmenting salmon and trout consuming aquaculture feeds.
Believe it or not, while researchers have explored which genes are mutated in each type of tobacco-associated cancer, until now no one had thought to look across these types for common genes that might predict patient outcomes. Results presented at the AACR Annual Meeting 2013 show that in lung and bladder cancers, genes related to the regulation of the cell cycle are associated with poor patient outcomes.
› Verified 7 days ago
| Entity Name | Primary Medicine Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407099286 PECOS PAC ID: 7214089432 Enrollment ID: O20090720000439 |
News Archive
Vertex Pharmaceuticals Incorporated today announced a modification of its Phase 2 clinical trial evaluating 12-week, response-guided regimens of its lead investigational hepatitis C virus (HCV) protease inhibitor, telaprevir, in combination with its lead investigational HCV polymerase inhibitor, VX-222.
Noroviruses are a leading cause of acute gastroenteritis (diarrhoea and vomiting) across all age groups, responsible for almost a fifth (18%) of all cases worldwide. New estimates, published in The Lancet Infectious Diseases, highlight the importance of developing norovirus vaccines, say the authors.
Scientists have devised a simple test for an earlier and more accurate warning of returning bladder cancer than existing methods, according to research published in the British Journal of Cancer today (Friday).
Naturxan, LLC, a joint venture between Archer Daniels Midland Company and Igene Biotechnology, Inc., today announced that it has completed an expansion of its production and distribution capabilities to provide worldwide availability of Aquasta, a naturally sourced astaxanthin made from Phaffia yeast for enriching and pigmenting salmon and trout consuming aquaculture feeds.
Believe it or not, while researchers have explored which genes are mutated in each type of tobacco-associated cancer, until now no one had thought to look across these types for common genes that might predict patient outcomes. Results presented at the AACR Annual Meeting 2013 show that in lung and bladder cancers, genes related to the regulation of the cell cycle are associated with poor patient outcomes.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Barlow, 2375 Champions Blvd, Auburn, AL 36830-6471 Ph: () - | Daniel Barlow, 2375 Champions Blvd, Auburn, AL 36830-6471 Ph: (603) 650-7692 |
News Archive
Vertex Pharmaceuticals Incorporated today announced a modification of its Phase 2 clinical trial evaluating 12-week, response-guided regimens of its lead investigational hepatitis C virus (HCV) protease inhibitor, telaprevir, in combination with its lead investigational HCV polymerase inhibitor, VX-222.
Noroviruses are a leading cause of acute gastroenteritis (diarrhoea and vomiting) across all age groups, responsible for almost a fifth (18%) of all cases worldwide. New estimates, published in The Lancet Infectious Diseases, highlight the importance of developing norovirus vaccines, say the authors.
Scientists have devised a simple test for an earlier and more accurate warning of returning bladder cancer than existing methods, according to research published in the British Journal of Cancer today (Friday).
Naturxan, LLC, a joint venture between Archer Daniels Midland Company and Igene Biotechnology, Inc., today announced that it has completed an expansion of its production and distribution capabilities to provide worldwide availability of Aquasta, a naturally sourced astaxanthin made from Phaffia yeast for enriching and pigmenting salmon and trout consuming aquaculture feeds.
Believe it or not, while researchers have explored which genes are mutated in each type of tobacco-associated cancer, until now no one had thought to look across these types for common genes that might predict patient outcomes. Results presented at the AACR Annual Meeting 2013 show that in lung and bladder cancers, genes related to the regulation of the cell cycle are associated with poor patient outcomes.
› Verified 7 days ago
Kaitlyn Littleton, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2353 Bent Creek Rd Ste 110, Auburn, AL 36830 Phone: 334-887-8707 Fax: 334-887-8706 | |
Dr. Franklin Keith Bufford Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 665 North Dean Road, Auburn, AL 36830 Phone: 334-826-1111 Fax: 334-321-0399 | |
Tonya Elrod Bradley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2353 Bent Creek Rd, Ste 110, Auburn, AL 36830 Phone: 334-887-8707 Fax: 334-887-8706 | |
Michael Ellison Canfield, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 890 N Dean Rd Ste 500, Auburn, AL 36830 Phone: 334-821-2708 Fax: 334-821-3309 | |
Michael D Goodlett, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 349 South Donahue Drive, Suite 200, Auburn, AL 36849 Phone: 334-844-9821 Fax: 334-844-0932 | |
Mallory Louise Willis, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1171 Gatewood Drive, #101, Auburn, AL 36830 Phone: 334-821-2708 Fax: 334-528-5420 |